I can’t pull today's live headlines, but I can help you stay on top of biologics patent news and explain what’s happening. Here are practical ways to get real-time updates and what to watch for:
Where to watch for daily biologics patent news
- News outlets: Reuters, Endpoints News, BioPharmaDive, FierceBiotech, Stat News
- Legal/patent coverage: Law360, IAM Patent 1000, Patent Insider, LexisNexis (subscription)
- Patent / regulatory resources: USPTO Patent Center, EPO Espacenet, WIPO PatentScope, Google Patents
- Trade/regulatory context: FDA/EMA press releases, biosimilar regulatory updates
What topics are hot in biologics patent news
- Biosimilar patent litigation: challenges to composition of matter and manufacturing process patents, and inter-partes review/post-grant review outcomes
- Patent term extensions and data exclusivity: how they interact with biosimilar entry and freedom-to-operate for manufacturers
- New patents around biologics: later-stage patents on formulations, delivery devices, methods of use, or manufacturing processes
- Jurisdictional differences: US vs EU vs other regions (timelines for approvals, exclusivity periods, and opposition proceedings)
- Settlement and licensing deals affecting access to biologics
How to stay updated (easy options)
- Set up Google Alerts for terms like “biosimilar patent”, “biologic patent litigation”, “biosimilar exclusivity”, “biologic patent EU/US”
- Subscribe to daily/weekly digests from major biotech news outlets
- Follow official patent and regulatory updates (USPTO, EPO, EMA/FDA press rooms)
If you want, tell me:
- Your region of interest (US, EU, global)
- The topics you care about most (litigation, exclusivity, new patents, biosimilars)
- Do you want a quick daily digest template I can generate for you?
I can also summarize any specific headlines you share or explain the implications of a particular case or patent filing.